Subscribe To
Adaptive Announces Launch of Epic Integration for clonoSEQ®
The Adaptive-Epic integration will provide clinicians and patients with easier access to minimal residual disease (MRD) monitoring in blood cancers SEATTLE, Sept. 13, 2023 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat […] The post Adaptive Announces Launch of Epic Integration for clonoSEQ® appeared first on ForexTV...
Read More
Posted: Sep 13 2023, 11:30
Author Name: forextv
Views: 111484